1-10 of 10
Tito Vanelli Costa, MD
Close
Sort by
Journal Articles

The Impact of Early Molecular Response in Event Free Survival in Patients with Chronic Myeloid Leukemia Treated with Imatinib

Laura Fogliatto, MD, Marcelo Eduardo Zanella Capra, MDPhD, Mariza Shaan, MD, Tito Vanelli Costa, MD, Mayde Seadi Torriani, Luis Carlos Zanandrea Contin, MD, Raquel Breunig, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Denise Almeida, MD, Marco Antônio Schilling, MD, Tânia Hellwig, MD, Tiago Daltoe, MD, Adriana Zardo, MD, Mariangela Moschen, MD, Moema Nene, MD, Juarez Fontoura Silveira, Tahiane Brum Soares, MD, Liane Esteves Daudt, MD PhD, João Friedrisch, Lucia Silla, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5536.
https://doi.org/10.1182/blood.V124.21.5536.5536
Published: 2014
Journal Articles

TKI Treatment Discontinuation: How Many Patients Could Stop Tyrosine Kinase Treatment According to Discontinuation Trials Criteria? Incidence and Prognostic Impact of Deep Molecular Response in a Cohort of Chronic Myeloid Leukemia Patients of South Brazil's Hematology Centers

Laura Fogliatto, MD, Marcelo Eduardo Zanella Capra, MDPhD, Mariza Shaan, MD, Tito Vanelli Costa, MD, Luis Carlos Zanandrea Contin, MD, Raquel Breunig, MD, Juarez Fontoura Silveira, Mayde Seadi Torriani, Katia Fassina, MD, Mario Sergio Fernandes, MD, Denise Almeida, MD, Marco Antonio Schilling, MD, Tânia Hellwig, MD, Tiago Daltoe, MD, Mariangela Moschen, MD, Adriana Zardo, MD, Moema Nene, MD, Liane Esteves Daudt, MD PhD, João Friedrisch, Lucia Silla, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5542.
https://doi.org/10.1182/blood.V124.21.5542.5542
Published: 2014
Journal Articles

The Assessment of the European Leukemianet Criteria for Clinicohematologic Resistance and Intolerance to Hydroxyurea in Polycythemia Vera Is Not Easily Applicable in Daily Practice

Laura Fogliatto, MD, Raquel Breunig, MD, Tito Vanelli Costa, MD, Luis Carlos Zanandrea Contin, MD, Juarez Fontoura Silveira, Cinara Silveira, Liane Esteves Daudt, MD PhD, Lucia Silla, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5550.
https://doi.org/10.1182/blood.V124.21.5550.5550
Published: 2014
Journal Articles

Warning As Defiened By European Leukemia Net 2013 (ELN 2013) In Chronic Phase Chronic Myeloid Leukemia (CP-CML) Corresponds To Warning In The Clinical Practice?

Laura Fogliatto, MD, Marcelo Capra, MD, Mariza Shaan, MD, Tito Vanelli Costa, MD, Raquel Breunig, MD, Christina G S Fraga, MD, Mayde Seadi Torriani, Lucia Silla, MD, PhD, Liane Esteves Daudt, MD, PhD, Mario Sérgio Fernandes, MD, Denise Almeida, MD, Marco Antônio Schilling, MD, Tânia Hellwig, MD, Katia Fassina, MD, Sabrina Wisintainer, MD, Mariangela Moschen, MD, Tiago Daltoe, MD, Adriana Zardo, MD, Juliana Kratochvil, MD, Viviane Magagnin Fernandes, MD, Cheila Eickhoff, MD, Moema Nene, MD, Saozan Ahmad, MD, Andréia Dias Almeida, MD, Vitor Lenz, MD
Journal: Blood
Blood (2013) 122 (21): 5176.
https://doi.org/10.1182/blood.V122.21.5176.5176
Published: 2013
Journal Articles

The Impact of Cytogenetic Response At 6 Months of Therapy in Global Survival of Patients with Chronic Myeloid Leukemia Treated with Imatinib in the South of Brazil

Laura Fogliatto, MD, Marcelo Capra, MD, Mariza Schaan, MD, Mario Sérgio Fernandes, MD, Tito Vanelli Costa, MD, Mayde Seadi Torriani, Katia Fassina, MD, Christina G S Fraga, MD, Mayla Baron, Dayane Koshiyama, Natássia Machado, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4453.
https://doi.org/10.1182/blood.V120.21.4453.4453
Published: 2012
Journal Articles

The Role of Early Cytogenetic Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib and the Impact of Adherence and Comorbidities

Laura Fogliatto, MD, Marcelo Capra, MD, Mariza Shaan, MD, Tito Vanelli Costa, MD, Mayde Seadi Torriani, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Denise Almeida, MD, Marco Antônio Schilling, MD, Tânia Hellwig, MD, Virgínia Coser, MD, Dalnei Veiga Pereira, MD, Waldir Veiga Pereira, MD, Sabrina Wisintainer, MD, Tiago Daltoe, MD, Mariangela Moschen, MD, Adriana Zardo, MD, Juliana Kratochvil, MD, Viviane Magagnin Fernandes, MD, Cheila Eickhoff, MD, Saozan Ahmad, MD, Andréia Dias Almeida, MD, Moema Nene, MD, Nathália Guterres Xavier, Dayane Koshiyama, Márcia Leite, MD, Vitor Lenz, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4423.
https://doi.org/10.1182/blood.V118.21.4423.4423
Published: 2011
Journal Articles

Determinants and Impact of Treatment Interruptions and Nonadherence to Imatinib Therapy in Patients with Chronic Myeloid Leukemia in a South Brazilian Cohort

Marcelo Capra, MD, Laura Fogliatto, MD, Mariza Shaan, MD, Mayde Seadi Torriani, Tito Vanelli Costa, MD, Mario Sérgio Fernandes, MD, Katia Fassina, MD, Denise Almeida, MD, Marco Antônio Schilling, MD, Tânia Hellwig, MD, Virgínia Coser, MD, Dalnei Veiga Pereira, MD, Waldir Veiga Pereira, MD, Mariangela Moschen, MD, Tiago Daltoe, MD, Sabrina Wisintainer, MD, Cheila Eickhoff, MD, Viviane Magagnin Fernandes, MD, Juliana Kratochvil, MD, Saozan Ahmad, MD, Adriana Zardo, MD, Andréia Dias Almeida, MD, Vitor Lenz, MD, Márcia Leite, MD, Moema Nene, MD, Dayane Koshiyama, Nathália Guterres Xavier, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4425.
https://doi.org/10.1182/blood.V118.21.4425.4425
Published: 2011
Journal Articles

Impact of Comorbidity In Event-Free Survival, Toxicity and Adherence to Treatment In Chronic Myeloid Leukemia Patients Treated with Imatinib

Laura Fogliatto, MD, Marcelo Capra, MD, Mariza Schaan, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Marco Antônio Schilling, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Gilca Nachtigal, MD, Adriana Zardo João, MD, Andréia Dias Almeida, MD, Tito Vanelli Costa, MD, Erica Lammerhirt Ottoni, MD, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2296.
https://doi.org/10.1182/blood.V116.21.2296.2296
Published: 2010
Journal Articles

Important Role of Early Therapy and Maintaining Uninterrupted Treatment In the Outcomes of Chronic Myelogenous Leukemia Patients Treated with Imatinib

Erica Lammerhirt Ottoni, MD, Marcelo Capra, MD, Mariza Schaan, MD, Marco Antônio Schilling, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Tito Vanelli Costa, MD, Adriana Zardo, MD, Andréia Dias Almeida, MD, Gilca Nachtigal, MD, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD, Laura Fogliatto, MD
Journal: Blood
Blood (2010) 116 (21): 2300.
https://doi.org/10.1182/blood.V116.21.2300.2300
Published: 2010
Journal Articles

Results of Imatinib Therapy In Patients with Early and Late Chronic-Phase Chronic Myeloid Leukemia In a South Brazilian Cohort.

Marcelo Capra, MD, Mariza Shaan, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Marco Antônio Schilling, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Gilca Nachtigal, MD, Adriana Zardo, MD, Andréia Dias Almeida, MD, Tito Vanelli Costa, MD, Erica Lammerhirt Ottoni, MD, Mayde Seadi Torriani, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD, Laura Fogliatto, MD
Journal: Blood
Blood (2010) 116 (21): 4487.
https://doi.org/10.1182/blood.V116.21.4487.4487
Published: 2010